retatrutide patent expiration semaglutide us As the patents on semaglutide, a popular diabetes and anti-obesity drug Will the FDA approve retatrutide?

Pharmacologists often use the five half-lives rule

Brain Behav Immun 55:8292 Shan Y, Tan S, Lin Y, Liao S, Zhang B, Chen X, Wang J, Deng Z, Zeng Q, Zhang L, Wang Y, Hu XQ, Qiu W, Peng L, Lu ZQ (2019) The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke

Supplements support a healthy lifestyle and are not a substitute for medical advice

2023 Aug 19;402(10402):613-626

Dosing started low and escalated gradually every four weeks, following the 'start low, go slow' protocol that reduces gastrointestinal side effects during the adjustment period

and permitting flexibility with food choices and occasional portion-controlled treats rather than severe restriction